Halozyme Therapeutics (HALO) Tops Q2 EPS by 30c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 130.91 -0.27 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.18 | 52 Week High | $18.39 | |||
| Open | $132.66 | 52 Week Low | $6.96 | |||
| Day High | $134.00 | P/E | N/A | |||
| Day Low | $130.31 | EPS | $-0.58 | |||
| Volume | 1,402,422 | |||||
